Your browser doesn't support javascript.
loading
Decoding the complexity of benign prostatic hyperplasia therapies in the PARTEM trial-authors' reply.
Sapoval, Marc; Déan, Carole; Pereira, Helena; Durand-Zaleski, Isabelle; Thiounn, Nicolas; Chatellier, Gilles.
Affiliation
  • Sapoval M; Université de Paris, PARCC - INSERM Unité-970, Paris, France.
  • Déan C; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Vascular and Oncological Interventional Radiology, Paris, France.
  • Pereira H; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Vascular and Oncological Interventional Radiology, Paris, France.
  • Durand-Zaleski I; INSERM, Centre d'investigation Clinique 1418 Épidémiologie Clinique, Paris, France.
  • Thiounn N; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Clinical Research Unit, Paris, France.
  • Chatellier G; Université de Paris, CRESS, INSERM UMR1153, INRA, Paris, France.
Lancet Reg Health Eur ; 37: 100821, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38362550
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health Eur Year: 2024 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health Eur Year: 2024 Document type: Article Affiliation country: Francia